{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T09:50:05Z","timestamp":1791021005649,"version":"4.1.0"},"reference-count":40,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[1999,11,1]],"date-time":"1999-11-01T00:00:00Z","timestamp":941414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[1999,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>\n            Culture and susceptibility testing of\n            <jats:italic>Helicobacter pylori<\/jats:italic>\n            strains was performed in a large multinational, multicenter randomized clinical trial. Culture was carried out on gastric biopsy samples obtained from 516 patients at entry and had a sensitivity of 99% when the [\n            <jats:sup>13<\/jats:sup>\n            C]urea breath test was used as a reference. Susceptibility testing was performed for clarithromycin and metronidazole on 485 strains by an agar dilution method and the epsilometer test (Etest) and for amoxicillin by an agar dilution method only. Resistance to clarithromycin (&gt;1 \u03bcg\/ml) was found in 3% of the\n            <jats:italic>H. pylori<\/jats:italic>\n            strains, with a perfect correlation between Etest and agar dilution methods. Resistance to metronidazole (&gt;8 \u03bcl\/ml) was found in 27% of the strains by agar dilution, but there were important discrepancies between it and the Etest method. No resistance to amoxicillin was found. The logarithms of the MICs of the three antibiotics against susceptible strains had a distribution close to normal. The impact of resistance was tested in the four arms of the trial. There were not enough clarithromycin-resistant strains to evaluate the impact of resistance on the cure rate of clarithromycin-based regimens. For metronidazole-resistant strains, the impact noted in the clarithromycin-metronidazole arm was partially overcome when omeprazole was added (76% eradication for resistant strains versus 95% for susceptible strains). Secondary resistance to clarithromycin occurred in strains from 12 of 105 patients (11.4%) after the failure of a clarithromycin-based regimen to effect eradication. The detection of point mutations in clarithromycin-resistant strains was performed by a combination of PCR and restriction fragment length polymorphism. Mutations (A2142G and 2143G) were found in all strains tested except one. This study stresses the importance of performing susceptibility tests in clinical trials in order to explain the results of different treatments.\n          <\/jats:p>","DOI":"10.1128\/aac.43.11.2747","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T00:33:39Z","timestamp":1539045219000},"page":"2747-2752","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":200,"title":["Antimicrobial Susceptibility Testing of\n            <i>Helicobacter pylori<\/i>\n            in a Large Multicenter Trial: the MACH 2 Study"],"prefix":"10.1128","volume":"43","author":[{"given":"Francis","family":"Me\u0301graud","sequence":"first","affiliation":[{"name":"<!--label omitted: 1-->Laboratoire de Bacte\u0301riologie, Ho\u0302pital Pellegrin, Bordeaux, France1;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Lehn","sequence":"additional","affiliation":[{"name":"<!--label omitted: 2-->Institut fu\u0308r Medizinische Mikrobiologie und Hygiene, University of Regensburg, Regensburg,2 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Lind","sequence":"additional","affiliation":[{"name":"<!--label omitted: 3-->Department of Surgery, Ka\u0308rnsjukhuset, Sko\u0308vde,3"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Bayerdo\u0308rffer","sequence":"additional","affiliation":[{"name":"<!--label omitted: 4-->Medizinische Klinik I, Gastroenterologie, Universita\u0308tsklinikum Carl Gustav Carus, Dresden,4 Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"O\u2019Morain","sequence":"additional","affiliation":[{"name":"<!--label omitted: 5-->Adelaide &amp; Meath Hospital, Trinity College Dublin, Tallaght, Dublin, Ireland5;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Spiller","sequence":"additional","affiliation":[{"name":"<!--label omitted: 6-->Division of Gastroenterology, Queen\u2019s Medical Centre, Nottingham, United Kingdom6; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Unge","sequence":"additional","affiliation":[{"name":"<!--label omitted: 7-->Department of Internal Medicine, Sandviken Hospital, Sandviken,7 and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sander Veldhuyzen","family":"van Zanten","sequence":"additional","affiliation":[{"name":"<!--label omitted: 8-->Department of Medicine, Queen Elizabeth II Hospital, Halifax, Nova Scotia, Canada8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Wrangstadh","sequence":"additional","affiliation":[{"name":"<!--label omitted: 9-->Astra Ha\u0308ssle, Mo\u0308lndal,9 Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl Fredrik","family":"Burman","sequence":"additional","affiliation":[{"name":"<!--label omitted: 9-->Astra Ha\u0308ssle, Mo\u0308lndal,9 Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/clinids\/12.Supplement_1.S107","article-title":"Diagnosis of Campylobacter pylori infections: the \u201cgold standard\u201d and the alternatives.","volume":"12","author":"Barthel J. S.","year":"1990","unstructured":"Barthel J. S. Everett E. D. Diagnosis of Campylobacter pylori infections: the \u201cgold standard\u201d and the alternatives. Rev. Infect. Dis. 12 (Suppl. 1) 1990 S107 S114","journal-title":"Rev. Infect. Dis."},{"key":"e_1_3_2_3_2","first-page":"A05","article-title":"Correlation between the MICs of metronidazole on H. pylori strains and the outcome of a lansoprazole-amoxicillin-metronidazole therapy.","volume":"39","author":"Bouchard S.","year":"1996","unstructured":"Bouchard S. Birac C. Lamouliatte H. Forestier S. M\u00e9graud F. Correlation between the MICs of metronidazole on H. pylori strains and the outcome of a lansoprazole-amoxicillin-metronidazole therapy. Gut 39 (Suppl. 2) 1996 A05 (Abstract.)","journal-title":"Gut"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1018882804607"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/jac\/29.2.115","article-title":"Proposed mechanism for metronidazole resistance in Helicobacter pylori.","volume":"29","author":"Cederbrant G.","year":"1992","unstructured":"Cederbrant G. Kahlmeter G. Ljungh A. Proposed mechanism for metronidazole resistance in Helicobacter pylori. J. Antimicrob. Chemother. 29 1992 115 120","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_6_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/31.1.65","article-title":"The Etest for antimicrobial susceptibility testing of Helicobacter pylori.","volume":"31","author":"Cederbrant G.","year":"1993","unstructured":"Cederbrant G. Kahlmeter G. Ljungh A. The Etest for antimicrobial susceptibility testing of Helicobacter pylori. J. Antimicrob. Chemother. 31 1993 65 71","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/BF01962615","article-title":"Evaluation of a new selective medium for Campylobacter pylori.","volume":"7","author":"Dent J. C.","year":"1988","unstructured":"Dent J. C. McNulty C. A. Evaluation of a new selective medium for Campylobacter pylori. Eur. J. Clin. Microbiol. Infect. Dis. 7 1988 555 558","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/43.1.47"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.9.2072-2075.1991"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1053\/gast.1996.v111.pm8690200","article-title":"Effect of omeprazole on the distribution of metronidazole, amoxicillin and clarithromycin in human gastric juice.","volume":"111","author":"Goddard A. F.","year":"1996","unstructured":"Goddard A. F. Jessa M. J. Barrett D. A. Shaw P. N. Idstr\u00f6m J. P. Cederberg C. Spiller R. C. Effect of omeprazole on the distribution of metronidazole, amoxicillin and clarithromycin in human gastric juice. Gastroenterology 111 1996 358 367","journal-title":"Gastroenterology"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.1998.00806.x"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.41.2.207"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.48.8.714"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.12.2634"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/jac\/32.1.45","article-title":"Comparison for the determination of the sensitivity of Helicobacter pylori to metronidazole.","volume":"32","author":"Hirschl A. M.","year":"1993","unstructured":"Hirschl A. M. Hirschl M. M. Rotter M. L. Comparison for the determination of the sensitivity of Helicobacter pylori to metronidazole. J. Antimicrob. Chemother. 32 1993 45 49","journal-title":"J. Antimicrob. Chemother."},{"key":"e_1_3_2_16_2","first-page":"A90","article-title":"Prospective assessment of the impact of primary antimicrobial resistance on cure rates of Helicobacter pylori infection.","volume":"41","author":"Kist M.","year":"1997","unstructured":"Kist M. Strobel S. F\u00f6lsch U. R. Kirchner T. Hahn E. G. van Kleist D. H. Kl\u00f6r H. U. Dammann H. G. Prospective assessment of the impact of primary antimicrobial resistance on cure rates of Helicobacter pylori infection. Gut 41 (Suppl. 1) 1997 A90","journal-title":"Gut"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.30.3.510"},{"key":"e_1_3_2_18_2","first-page":"248","article-title":"Highly effective twice-daily triple therapies for H. pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance?","volume":"92","author":"Lerang F.","year":"1997","unstructured":"Lerang F. Moum B. Haug J. B. Tolas P. Breder O. Aubert E. Hoie O. Soberg T. Flaaten B. Farup P. Berge T. Highly effective twice-daily triple therapies for H. pylori infection and peptic ulcer disease: does in vitro metronidazole resistance have any clinical relevance? Am. J. Gastroenterol. 92 1997 248 253","journal-title":"Am. J. Gastroenterol."},{"key":"e_1_3_2_19_2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0016-5085(99)70119-8","article-title":"The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies.","volume":"116","author":"Lind T.","year":"1999","unstructured":"Lind T. M\u00e9graud F. Unge P. Bayerd\u00f6rffer E. O\u2019Morain C. Spiller R. van Zanten S. V. Bardhan K. D. Hellblom M. Wrangstadh M. Zeijlon L. Cederberg C. The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology 116 1999 248 253","journal-title":"Gastroenterology"},{"key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1523-5378.1996.tb00027.x","article-title":"Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH1 study.","volume":"3","author":"Lind T.","year":"1996","unstructured":"Lind T. van Zanten S. V. Unge P. Spiller R. Bayerd\u00f6rffer E. O\u2019Morain C. Bardhan K. D. Bradette M. Chiba N. Wrangstadh M. Cederberg C. Idstrom J. P. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH1 study. Helicobacter 3 1996 138 144","journal-title":"Helicobacter"},{"key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/biomet\/63.3.655","article-title":"On closed testing procedures with special reference to ordered analysis of variance.","volume":"63","author":"Marcus R.","year":"1976","unstructured":"Marcus R. Peritz E. Gabriel K. R. On closed testing procedures with special reference to ordered analysis of variance. Biometrika 63 1976 655 660","journal-title":"Biometrika"},{"key":"e_1_3_2_22_2","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00365529609094536","article-title":"Advantages and disadvantages of current diagnostic tests for the detection of Helicobacter pylori.","volume":"31","author":"M\u00e9graud F.","year":"1996","unstructured":"M\u00e9graud F. Advantages and disadvantages of current diagnostic tests for the detection of Helicobacter pylori. Scand. J. Gastroenterol. 31 (Suppl. 215) 1996 57 62","journal-title":"Scand. J. Gastroenterol."},{"key":"e_1_3_2_23_2","first-page":"249","article-title":"Diagnostic bact\u00e9riologique standard de l\u2019infection \u00e0 Helicobacter pylori","volume":"1","author":"M\u00e9graud F.","year":"1996","unstructured":"M\u00e9graud F. Diagnostic bact\u00e9riologique standard de l\u2019infection \u00e0 Helicobacter pylori Helicobacter pylori M\u00e9graud F. Lamouliatte H. 1 1996 249 276 Elsevier Paris, France","journal-title":"Helicobacter pylori"},{"key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0016-5085(97)80020-0","article-title":"How should Helicobacter pylori infection be diagnosed?","volume":"113","author":"M\u00e9graud F.","year":"1997","unstructured":"M\u00e9graud F. How should Helicobacter pylori infection be diagnosed? Gastroenterology 113 1997 S93 S98","journal-title":"Gastroenterology"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70101-5"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.22.6.1007-1010.1985"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.43.2008.S61"},{"key":"e_1_3_2_28_2","unstructured":"M\u00e9graud\n              F.\n              Lamouliatte\n              H.\n              Bouchard\n              S.\n              Birac\n              C.\n              Villeval\n              F.\n          Evaluation of a transport medium: Portagerm pylori for Helicobacter pylori abstr. 1040.\n          Abstracts of the European Congress on Clinical Microbiology and Infectious Diseases\n          1991"},{"key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1136\/gut.41.6.735","article-title":"One week triple therapy for Helicobacter pylori: a multicentre comparative study.","volume":"41","author":"Misiewicz J. J.","year":"1997","unstructured":"Misiewicz J. J. Harris A. W. Bardhan K. D. Levi S. O\u2019Morain C. Cooper B. T. Kerr G. D. Dixon M. F. Langworthy H. Piper D. One week triple therapy for Helicobacter pylori: a multicentre comparative study. Gut 41 1997 735 739","journal-title":"Gut"},{"key":"e_1_3_2_30_2","first-page":"A6","article-title":"Prevalence of metronidazole in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate H. pylori.","volume":"39","author":"Moayyedi P.","year":"1996","unstructured":"Moayyedi P. Tompkins D. S. Ragunathan P. L. Axon A. T. R. Prevalence of metronidazole in predicting failure of omeprazole, clarithromycin and tinidazole to eradicate H. pylori. Gut 39 (Suppl. 2) 1996 A6 (Abstract.)","journal-title":"Gut"},{"key":"e_1_3_2_31_2","unstructured":"National Committee for Clinical Laboratory Standards\n          Performance standards for antimicrobial susceptibility testing. VIth informational supplement. M100S9 19 1.\n          1999\n          National Committee for Clinical Laboratory Standards\n          Villanova Pa"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.41.12.2724"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.35.7.1842-1846.1997"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/36.3.453"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1128\/jcm.29.11.2587-2589.1991"},{"key":"e_1_3_2_36_2","unstructured":"Utrup\n              L. J.\n              Flamm\n              R.\n              Osato\n              M.\n              Ferraro\n              M. J.\n              Reller\n              L. B.\n              Barry\n              A.\n              Bush\n              K.\n              Silliman\n              N.\n          Susceptibility testing standardization and quality control ranges for Helicobacter pylori abstr. C-31.\n          Program and abstracts of the 98th General Meeting of the American Society for Microbiology 1998.\n          1998\n          American Society for Microbiology\n          Washington D.C."},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)00064-6"},{"key":"e_1_3_2_38_2","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/BF02088756","article-title":"Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori.","volume":"41","author":"Veldhuyzen van Zanten S. J.","year":"1996","unstructured":"Veldhuyzen van Zanten S. J. Pollak P. T. Kapoor H. Yeung P. K. Effect of omeprazole on movement of intravenously administered metronidazole into gastric juice and its significance in treatment of Helicobacter pylori. Dig. Dis. Sci. 41 1996 1845 1852","journal-title":"Dig. Dis. Sci."},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.40.2.477"},{"key":"e_1_3_2_40_2","first-page":"48","article-title":"Improved growth of Helicobacter pylori using a liquid medium supplemented with human serum.","volume":"23","author":"Westblom T. U.","year":"1991","unstructured":"Westblom T. U. Gudip\u00e2ti S. Madan E. Midkiff B. R. Improved growth of Helicobacter pylori using a liquid medium supplemented with human serum. Ital. J. Gastroenterol. 23 (Suppl. 2) 1991 48 (Abstract.)","journal-title":"Ital. J. Gastroenterol."},{"key":"e_1_3_2_41_2","first-page":"943","article-title":"Short-course therapy with amoxicillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group Aliment.","volume":"11","author":"Wurzer H.","year":"1997","unstructured":"Wurzer H. Rodrigo L. Stamler D. Archambault A. Rokkas T. Skandalis N. Fedorak R. Bazzoli F. Hentschel E. Mora P. Archimandritis A. M\u00e9graud F. Short-course therapy with amoxicillin-clarithromycin triple therapy for 10 days (ACT-10) eradicates Helicobacter pylori and heals duodenal ulcer. ACT-10 Study Group Aliment. Pharmacol. Ther. 11 1997 943 952","journal-title":"Pharmacol. Ther."}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.11.2747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.43.11.2747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T15:59:15Z","timestamp":1645459155000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.43.11.2747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[1999,11]]}},"alternative-id":["10.1128\/AAC.43.11.2747"],"URL":"https:\/\/doi.org\/10.1128\/aac.43.11.2747","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,11]]},"assertion":[{"value":"1999-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-08-28","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"1999-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}